Given that in the last two years, China’s 13th 5-Year Plan was adopted, ‘Made in China 2025’ promoted, the High & New Technology Enterprise Regulations substantially amended, and an entirely new IP-Courts system implemented, and that the next two years will see far reaching amendments to both China’s Patent Law (the much heralded ‘4th Amendment’) and Employee-Inventor Remuneration Regulations, speaking of the “new normal” for China, most definitely does not apply to changes to the Framework for IP nor for Innovation.

• 2016-11-18 | 09:00 - 12:00
• Jones Day Shanghai Office